Regent Pacific Group Limited (RPGLF)

Market Cap	29.68M
Revenue (ttm)	719.00K
Net Income (ttm)	-4.48M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Average Volume	1,088
Open	0.0007
Previous Close	0.0007
Day's Range	0.0007 - 0.0007
52-Week Range	0.0007 - 0.1000
Beta	1.06
RSI	45.03
Earnings Date	May 28, 2025

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 17
• Stock Exchange: OTCMKTS
• Ticker Symbol: RPGLF

Financial Performance

In 2024, Regent Pacific Group's revenue was $719,000, an increase of 147.08% compared to the previous year's $291,000. Losses were -$4.48 million, -82.11% less than in 2023.